MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Low serum vitamin E in a genetically confirmed Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)

    D. Al-Shorafat, K. Al-Hayk, M. Qawasmeh, W. Kamel, S. Bashayreh (Irbid, Jordan)

    Objective: To report a case of ARSACS associated with low serum vitamin E. Background: Ataxia with vitamin E deficiency (AVED) presentation varies but usually starts…
  • 2023 International Congress

    Wilson disease: a single-center study from Tunisia

    R. Zouari, R. Amouri, I. Ben Kraiem, MZ. Saeid, F. Nabli, S. Ben Sassi (Tunis, Tunisia)

    Objective: We aimed to describe different clinical and radiological presentations of WD and insist on the necessity of early diagnosis to ensure therapeutic efficiency. Background:…
  • 2023 International Congress

    The contribution of Brain Bank for Aging Research to pathomechanism of Parkinson’s disease

    S. Murayama, Y. Saito (Osaka, Japan)

    Objective: Objective: The aim of this paper is to present the result of the whole body screening of Lewy body pathology by Brain Bank for…
  • 2023 International Congress

    Prevalence of seizures in patients with Neurodegeneration with Brain Iron Accumulation

    D. Kalikavil Puthanveedu, A. Cherian (Thiruvananthapuram, India)

    Objective: To investigate the frequency and pattern of seizures in Neurodegeneration with brain iron accumulation (NBIA) disorders in a South Indian cohort. Background: Seizure as…
  • 2023 International Congress

    The diagnosis value of dopaminergic responsiveness of Parkinson’s disease: a systematic review and meta-analysis

    WY. Kou, HH. Cai, FT. Feng (beijiing, China)

    Objective: aimed to confirm the diagnostic value/accuracy of levodopa and/or apomorphine challenge test in parkinsonian syndromes (PDS) to assess their value in the diagnosis of…
  • 2023 International Congress

    Clinal comprehensive Next-gen gene panel for Parkinson’s Disease

    Z. Niu, E. Lauer, S. Roellinger, L. Hasadsri, O. Ross, R. Savica (Rochester, USA)

    Objective: Parkinson's disease (PD) is a neurodegenerative disorder that affects millions of people. There is growing evidence on both gene mutations associated with PD and…
  • 2023 International Congress

    Telemedicine challenges in the management of patients with Parkinson’s disease in Central Asia.

    A. Iliazova, E. Zhunusova, C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: The aim of the study is to identify challenges for telemedicine in treatment among patients with parkinsonism in Kyrgyzstan and Kazakhstan. Background: The covid-19…
  • 2023 International Congress

    Amplifying or suppressing subthalamic beta oscillations in real-time in Parkinson’s disease using evoked interference deep brain stimulation (eiDBS): feasibility in the human

    D. Escobar, B. Campbell, S. Mesbah, L. Favi Bocca, J. Liao, R. Rammo, S. Nagel, A. Machado, K. Baker (Cleveland, USA)

    Objective: ​​​​​ ​​To assess the feasibility of continuously amplifying or suppressing subthalamic beta oscillations in real-time in Parkinson's disease (PD) patients using a bidirectional, closed-loop brain…
  • 2023 International Congress

    Be aware of Involuntary Emotional Expressive Disorder: a neurological syndrome, not a mood disorder

    V. Balasubramaniam, L. Baytieh (WOLLONGONG, Australia)

    Objective: To increase awareness of Involuntary Emotional Expressive Disorder (IEED) in clinicians assessing patients affected with involuntary laughter and/or crying variants (in stroke and traumatic…
  • 2023 International Congress

    Genetic diagnosis of parkinsonian phenotype of Machado Joseph Diseasep (SCA-3) presenting with dopa induced dyskinesia

    D. Chaudhari, A. Mishra, P. Renjen, K. Ahmad, N. Sahu (New Delhi, India)

    Objective: We report a rare type IV parkinsonian phenotype of MJD having a rare genetic mutation. SCA type 3 (SCA3), also known as Machado-Joseph disease…
  • « Previous Page
  • 1
  • …
  • 407
  • 408
  • 409
  • 410
  • 411
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley